Literature DB >> 20434968

Bile salts and cholestasis.

Lucas Maillette de Buy Wenniger1, Ulrich Beuers.   

Abstract

Bile salts have a crucial role in hepatobiliary and intestinal homeostasis and digestion. Primary bile salts are synthesized by the liver from cholesterol, and may be modified by the intestinal flora to form secondary and tertiary bile salts. Bile salts are efficiently reabsorbed from the intestinal lumen to undergo enterohepatic circulation. In addition to their function as a surfactant involved in the absorption of dietary lipids and fat-soluble vitamins bile salts are potent signaling molecules in both the liver and intestine. Under physiological conditions the bile salt pool is tightly regulated, but the adaptive capacity may fall short under cholestatic conditions. Elevated serum and tissue levels of potentially toxic hydrophobic bile salts during cholestasis may cause mitochondrial damage, apoptosis or necrosis in susceptible cell types. Therapeutic nontoxic bile salts may restore impaired hepatobiliary secretion in cholestatic disorders. The hydrophilic bile salt ursodeoxycholate is today regarded as the effective standard treatment of primary biliary cirrhosis and intrahepatic cholestasis of pregnancy, and is implicated for use in various other cholestatic conditions. Novel therapeutic bile salts that are currently under evaluation may also prove valuable in the treatment of these diseases. Copyright 2010. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20434968     DOI: 10.1016/j.dld.2010.03.015

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  49 in total

1.  The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway.

Authors:  Dong-ke Yu; Cai-xia Zhang; Shuang-shuang Zhao; Sheng-hua Zhang; Hao Zhang; Shi-ying Cai; Rong-guang Shao; Hong-wei He
Journal:  Acta Pharmacol Sin       Date:  2015-03-16       Impact factor: 6.150

Review 2.  A Change in Bile Flow: Looking Beyond Transporter Inhibition in the Development of Drug-induced Cholestasis.

Authors:  Brandy Garzel; Lei Zhang; Shiew-Mei Huang; Hongbing Wang
Journal:  Curr Drug Metab       Date:  2019       Impact factor: 3.731

3.  Dexmedetomidine activates the PI3K/Akt pathway to inhibit hepatocyte apoptosis in rats with obstructive jaundice.

Authors:  Yaying Xie; Chunyan Guo; Ye Liu; Luanyuan Shi; Jianshe Yu
Journal:  Exp Ther Med       Date:  2019-10-08       Impact factor: 2.447

4.  Hepatic encephalopathy induces site-specific changes in gene expression of GluN1 subunit of NMDA receptor in rat brain.

Authors:  Shamseddin Ahmadi; Mahsa Poureidi; Jalal Rostamzadeh
Journal:  Metab Brain Dis       Date:  2015-04-22       Impact factor: 3.584

5.  Protective effect of bicyclol against bile duct ligation-induced hepatic fibrosis in rats.

Authors:  Yong-Zhan Zhen; Na-Ren Li; Hong-Wei He; Shuang-Shuang Zhao; Guang-Ling Zhang; Xiao-Fang Hao; Rong-Guang Shao
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

6.  Sodium taurocholate cotransporting polypeptide mediates dual actions of deoxycholic acid in human hepatocellular carcinoma cells: enhanced apoptosis versus growth stimulation.

Authors:  Eun Sun Jang; Jung-Hwan Yoon; Sung-Hee Lee; Soo-Mi Lee; Jeong-Hoon Lee; Su Jong Yu; Yoon Jun Kim; Hyo-Suk Lee; Chung Yong Kim
Journal:  J Cancer Res Clin Oncol       Date:  2013-11-27       Impact factor: 4.553

7.  Plasma biomarkers of liver injury and inflammation demonstrate a lack of apoptosis during obstructive cholestasis in mice.

Authors:  Benjamin L Woolbright; Daniel J Antoine; Rosalind E Jenkins; Mary Lynn Bajt; B Kevin Park; Hartmut Jaeschke
Journal:  Toxicol Appl Pharmacol       Date:  2013-10-03       Impact factor: 4.219

8.  High prevalence of vitamin A deficiency and vitamin D deficiency in patients evaluated for liver transplantation.

Authors:  Mukund Venu; Eric Martin; Kia Saeian; Samer Gawrieh
Journal:  Liver Transpl       Date:  2013-04-15       Impact factor: 5.799

Review 9.  Novel insight into mechanisms of cholestatic liver injury.

Authors:  Benjamin L Woolbright; Hartmut Jaeschke
Journal:  World J Gastroenterol       Date:  2012-09-28       Impact factor: 5.742

10.  Modulation of the fecal bile acid profile by gut microbiota in cirrhosis.

Authors:  Genta Kakiyama; William M Pandak; Patrick M Gillevet; Phillip B Hylemon; Douglas M Heuman; Kalyani Daita; Hajime Takei; Akina Muto; Hiroshi Nittono; Jason M Ridlon; Melanie B White; Nicole A Noble; Pamela Monteith; Michael Fuchs; Leroy R Thacker; Masoumeh Sikaroodi; Jasmohan S Bajaj
Journal:  J Hepatol       Date:  2013-01-16       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.